| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.054 | 0.07 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.086 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.08 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |